These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Advancing chemistry and biology through diversity-oriented synthesis of natural product-like libraries. Shang S; Tan DS Curr Opin Chem Biol; 2005 Jun; 9(3):248-58. PubMed ID: 15939326 [TBL] [Abstract][Full Text] [Related]
44. Lessons from natural molecules. Clardy J; Walsh C Nature; 2004 Dec; 432(7019):829-37. PubMed ID: 15602548 [TBL] [Abstract][Full Text] [Related]
45. Novel approaches to plant drug discovery based on high throughput pharmacological screening and genetic manipulation. Littleton J; Rogers T; Falcone D Life Sci; 2005 Dec; 78(5):467-75. PubMed ID: 16274700 [TBL] [Abstract][Full Text] [Related]
46. Natural products drug discovery research in India: status and appraisal. Bhutani KK; Gohil VM Indian J Exp Biol; 2010 Mar; 48(3):199-207. PubMed ID: 21046972 [TBL] [Abstract][Full Text] [Related]
47. Natural products and antifungal drug discovery. Jacob MR; Walker LA Methods Mol Med; 2005; 118():83-109. PubMed ID: 15888937 [TBL] [Abstract][Full Text] [Related]
48. Natural products drug discovery: accelerating the clinical candidate development using reverse pharmacology approaches. Patwardhan B; Vaidya AD Indian J Exp Biol; 2010 Mar; 48(3):220-7. PubMed ID: 21046974 [TBL] [Abstract][Full Text] [Related]
49. Wanted: new multicomponent reactions for generating libraries of polycyclic natural products. Ulaczyk-Lesanko A; Hall DG Curr Opin Chem Biol; 2005 Jun; 9(3):266-76. PubMed ID: 15939328 [TBL] [Abstract][Full Text] [Related]
50. Natural products as sources of new drugs over the period 1981-2002. Newman DJ; Cragg GM; Snader KM J Nat Prod; 2003 Jul; 66(7):1022-37. PubMed ID: 12880330 [TBL] [Abstract][Full Text] [Related]
51. Discovery of chemical reactions through multidimensional screening. Beeler AB; Su S; Singleton CA; Porco JA J Am Chem Soc; 2007 Feb; 129(5):1413-9. PubMed ID: 17263426 [TBL] [Abstract][Full Text] [Related]
52. Natural compounds: leads or ideas? Bioinspired molecules for drug discovery. Beghyn T; Deprez-Poulain R; Willand N; Folleas B; Deprez B Chem Biol Drug Des; 2008 Jul; 72(1):3-15. PubMed ID: 18554253 [TBL] [Abstract][Full Text] [Related]
54. Virtual screening - what does it give us? Köppen H Curr Opin Drug Discov Devel; 2009 May; 12(3):397-407. PubMed ID: 19396741 [TBL] [Abstract][Full Text] [Related]
56. Characterizing biological products and assessing comparability following manufacturing changes. Chirino AJ; Mire-Sluis A Nat Biotechnol; 2004 Nov; 22(11):1383-91. PubMed ID: 15529163 [TBL] [Abstract][Full Text] [Related]
57. Solvent derived artifacts in natural products chemistry. Maltese F; van der Kooy F; Verpoorte R Nat Prod Commun; 2009 Mar; 4(3):447-54. PubMed ID: 19413130 [TBL] [Abstract][Full Text] [Related]
58. Hit discovery and hit-to-lead approaches. Keseru GM; Makara GM Drug Discov Today; 2006 Aug; 11(15-16):741-8. PubMed ID: 16846802 [TBL] [Abstract][Full Text] [Related]
59. [Application of liquid chromatography-spectroscopy coupled techniques to the chemical screening of natural products]. Si DY; Zhong DF Yao Xue Xue Bao; 2002 Jun; 37(6):485-9. PubMed ID: 12579813 [No Abstract] [Full Text] [Related]
60. A renaissance in marine pharmacology: from preclinical curiosity to clinical reality. Glaser KB; Mayer AM Biochem Pharmacol; 2009 Sep; 78(5):440-8. PubMed ID: 19393227 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]